A Study of CHS-114 in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

154

Participants

Timeline

Start Date

April 1, 2025

Primary Completion Date

May 31, 2027

Study Completion Date

May 31, 2027

Conditions
Metastatic Solid TumorAdvanced Solid Tumor
Interventions
DRUG

CHS-114

Solution for infusion

DRUG

Toripalimab

Solution for infusion

DRUG

5 Fluorouracil

Solution for infusion

DRUG

Cisplatin

Solution for infusion

Trial Locations (17)

112

RECRUITING

Taipei Veterans General Hospital, Taipei

704

RECRUITING

National Cheng Kung University Hospital, Tainan City

10002

RECRUITING

National Taiwan University Hospital, Taipei

10065

RECRUITING

David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York

15232

RECRUITING

University of Pittsburg Medical Center _UPMC Hillman Cancer Center, Pittsburgh

22031

RECRUITING

Virginia Cancer Specialists, Fairfax

23502

RECRUITING

Virginia Oncology Associates, Norfolk

29605

RECRUITING

Prisma Health Cancer Institute, Greenville

37203

RECRUITING

SCRI Oncology Partners, Nashville

40705

RECRUITING

Taichung Veterans General Hospital, Taichung

70121

RECRUITING

Ochsner Health, New Orleans

78731

RECRUITING

Texas Oncology - Central South, Austin

84112

RECRUITING

Huntsman Cancer Institute, University of Utah, Salt Lake City

85724

RECRUITING

The University of Arizona Cancer Center, Tucson

87505

RECRUITING

Christus St Vincent Regional Medical Center, Santa Fe

91010

RECRUITING

City of Hope, Duarte

Unknown

RECRUITING

China Medical University Hospital, Taichung

Sponsors
All Listed Sponsors
lead

Coherus Oncology, Inc.

INDUSTRY